Lexaria Granted Patent #21: Compositions and Methods for Treating Hypertension And #24: Compositions and Methods for Treating Epilepsy.
Portfolio Pulse from Benzinga Newsdesk
Lexaria has been granted two new patents: Patent #21 for compositions and methods for treating hypertension, and Patent #24 for compositions and methods for treating epilepsy.
May 21, 2024 | 1:32 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Lexaria has been granted two new patents, which could enhance its market position and product offerings in the treatment of hypertension and epilepsy.
The granting of these patents could lead to new product developments and potential revenue streams for Lexaria, positively impacting its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100